Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinomaJunjie Yu，Utpal B.Pajvani544-546
Immunotherapy prototype Mark 3.0 model in primary liver cancer:adding locoregional stereotactic therapy and prognostic factors classification managementXu Yang，Nan Zhang，Yang Song，Xiaobo Yang，Xinting Sang，Haitao Zhao547-552
Precision intervention of cell type-specific targeting is required for future cancer immunotherapyYitong Cai，Anli Zhang，Changzheng Lu553-554
Therapeutic antibodies for precise cancer immunotherapy:current and future perspectivesLongchao Liu，Jiahui Chen555-569
Understanding recurrent pregnancy loss:recent advances on its etiology,clinical diagnosis,and managementChunwei Cao，Shiyu Bai，Jing Zhang，Xiaoyue Sun，Anming Meng，Hui Chen570-589
Atypical functions of xenobiotic receptors in lipid and glucose metabolismJingyuan Wang，Peipei Lu，Wen Xie611-624
